Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine › Research Explorer

DOI

https://doi.org/10.3390/molecules29184498
Final published version

Daria S. Gorina
Anastasiya V. Lastovka
Artem D. Rogachev
Alexandra V. Podturkina
Alla V. Pavlova
Oleg V. Ardashov
Nikolai S. Li-Zhulanov
Tatyana G. Tolstikova
Konstantin P. Volcho
Nariman F. Salakhutdinov

Original language	English
Article number	4498
Journal	Molecules
Volume	29
Issue number	18
DOIs	https://doi.org/10.3390/molecules29184498
Publication status	Published - Sept 2024

Research areas

Animals, Mice, Antiparkinson Agents/pharmacokinetics, Male, Triazoles/pharmacokinetics, Tandem Mass Spectrometry, Dose-Response Relationship, Drug, Biological Availability, Parkinson Disease/drug therapy, Administration, Oral, Chromatography, High Pressure Liquid, Mice, Inbred C57BL, Disease Models, Animal

OECD FOS+WOS

1.06.CQ BIOCHEMISTRY & MOLECULAR BIOLOGY
1.04.EE CHEMISTRY, ORGANIC
1.04.DY CHEMISTRY, MULTIDISCIPLINARY

ID: 60797162